Get started
Author

Christian R Schultze-Florey

Observed names: C. Schultze-Florey, C. Schultze‐Florey, C.R. Schultze-Florey, Christian R. Schultze-Florey, Christian Schultze-Florey, Christian Schultze‐Florey, Schultze-Florey, Christian R.
ORCID: 0000-0002-3307-2639
Observed ORCID: 0000-0002-3307-2639
OpenAlex ID: A5081490540
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
2021 · Joana Barros-Martins, Swantje I. Hammerschmidt, et al. · Nature Medicine · 425
PDF
Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection
2017 · Sarina Ravens, Christian Schultze-Florey, et al. · Nature Immunology · 271
Reappearance of effector T cells is associated with recovery from COVID-19
2020 · Ivan Odak, Joana Barros-Martins, et al. · EBioMedicine · 135
PDF
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
2020 · Berislav Bošnjak, Saskia Catherina Stein, et al. · Cellular and Molecular Immunology · 115
PDF
A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthood
2021 · Likai Tan, Alina Suzann Fichtner, et al. · Science Immunology · 110
PDF
When grief makes you sick: Bereavement induced systemic inflammation is a question of genotype
2012 · Christian R. Schultze-Florey, Otoniel Martínez-Maza, et al. · Brain Behavior and Immunity · 92
Divergent gene expression responses to Complicated Grief and Non-complicated Grief
2014 · Mary-Frances O’Connor, Christian R. Schultze-Florey, et al. · Brain Behavior and Immunity · 47
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
2022 · Georg M. N. Behrens, Joana Barros-Martins, et al. · Nature Communications · 44
PDF
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma
2025 · Evgenii Shumilov, Julia Katharina Scholz, et al. · Blood Advances · 41
PDF
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy
2022 · Nora Möhn, Viktoria Bonda, et al. · Neurological Research and Practice · 36
PDF
18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
2020 · Thorsten Derlin, Christian Schultze-Florey, et al. · Annals of Nuclear Medicine · 36
PDF
Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
2018 · Rebecca E. Schultze-Florey, Sabine Tischer, et al. · Frontiers in Immunology · 35
PDF
Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy
2018 · Sarina Ravens, Julia Hengst, et al. · Frontiers in Immunology · 31
PDF
Distribution of major lymphocyte subsets and memory T-cell subpopulations in healthy adults employing GLP-conforming multicolor flow cytometry
2021 · Christian R. Schultze-Florey, Ekaterina Chukhno, et al. · Leukemia · 26
PDF
TCR repertoire analysis reveals phosphoantigen-induced polyclonal proliferation of Vγ9Vδ2 T cells in neonates and adults
2020 · Alina S Fichtner, Anja Bubke, et al. · Journal of Leukocyte Biology · 26
Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy
2019 · Chai Fen Soon, Shihong Zhang, et al. · Frontiers in Immunology · 18
PDF
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI
2021 · Christian R. Schultze-Florey, Leonie Kuhlmann, et al. · Blood Advances · 16
611O Updated results from BNT211-01 (NCT04503278), an ongoing, first-in-human, phase I study evaluating safety and efficacy of CLDN6 CAR T cells and a CLDN6-encoding mRNA vaccine in patients with relapsed/refractory CLDN6+ solid tumors
2024 · J.B.A.G. Haanen, A. Mackensen, et al. · Annals of Oncology · 15
PDF
Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation
2017 · Justyna Ogonek, Kriti Verma, et al. · The Journal of Immunology · 15
Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse
2022 · Ivan Odak, Ruth Sikora, et al. · Frontiers in Immunology · 11
PDF
Publisher Correction: Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection
2018 · Sarina Ravens, Christian Schultze-Florey, et al. · Nature Immunology · 11
PDF
Focusing of the regulatory T-cell repertoire after allogeneic stem cell transplantation indicates protection from graft-versus-host disease
2019 · Ivan Odak, Solaiman Raha, et al. · Haematologica · 10
PDF
Point-of-Care Anti–CD19-CAR T-cell Therapy Induces Renal Remission in Refractory Myeloperoxidase–Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
2025 · Christian R. Schultze-Florey, Vega Gödecke, et al. · Kidney International Reports · 9
PDF
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
2022 · Michael Stadler, Letizia Venturini, et al. · Frontiers in Oncology · 9
Anti-CD19 CAR-T cell therapy for acquired hemophilia A
2025 · Christian R. Schultze-Florey, Felicitas R. Thol, et al. · Leukemia · 8
Works count: 64
Citation count: 1,652
H-index: 16
I10-index: 22
Year
Topic
Type